Avricore Health (AVCRF) Cash from Financing Activities (2014 - 2024)
Avricore Health (AVCRF) posted quarterly Cash from Financing Activities of $28755.1 for Q3 2024, up 391.31% quarter-over-quarter from -$9870.8 in Q2 2024.
Avricore Health (AVCRF) Cash from Financing Activities (2014 - 2024) Analysis & Trends
Avricore Health (AVCRF) has reported Cash from Financing Activities for 11 consecutive years, with $28755.1 the latest figure, recorded in Q3 2024.
- In Q3 2024, Cash from Financing Activities changed N/A year-over-year to $28755.1; the TTM figure through Sep 2024 stood at $8197.8 (down 95.68% YoY), while the FY2024 annual figure was $41340.6, up 31.24% from the prior year.
- Cash from Financing Activities rose to $28755.1 in Q3 2024 per AVCRF's latest filing, from -$9870.8 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $2.0 million in Q1 2021 and bottomed at -$10686.4 in Q1 2024.
- Historically, Cash from Financing Activities has averaged $238131.4 across 5 years, with a median of $28801.6 in 2020.
- Annual changes were most pronounced in 2021 — Cash from Financing Activities soared 29339.31% — and 2024, when it plunged 188.39%.
- Avricore Health's Cash from Financing Activities stood at $473420.0 in 2020, then tumbled by 87.11% to $61042.5 in 2021, then surged by 159.33% to $158302.7 in 2022, then slumped by 92.95% to $11166.8 in 2023, then jumped by 157.51% to $28755.1 in 2024.
- Business Quant data shows AVCRF's Cash from Financing Activities at $28755.1 in Q3 2024, -$9870.8 in Q2 2024, and -$10686.4 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 28,755.06 |
| Sep 30, 2024 | 28,755.06 |
| Jun 30, 2024 | -9,870.80 |
| Jun 30, 2024 | -9,870.80 |
| Mar 31, 2024 | -10,686.43 |
| Mar 31, 2024 | -10,686.43 |
| Jun 30, 2023 | 11,166.79 |
| Jun 30, 2023 | 11,166.79 |
| Mar 31, 2023 | 20,341.65 |
| Mar 31, 2023 | 20,341.65 |
| Dec 31, 2022 | 158,302.73 |
| Dec 31, 2022 | 158,302.73 |
| Sep 30, 2022 | 11,501.19 |
| Sep 30, 2022 | 11,501.19 |
| Mar 31, 2022 | 18,947.41 |
| Mar 31, 2022 | 18,947.41 |
| Dec 31, 2021 | 61,042.45 |
| Dec 31, 2021 | 61,042.45 |
| Sep 30, 2021 | 259,791.70 |
| Sep 30, 2021 | 259,791.70 |